AILBRY - Article Search
Serach over 250 million academic articles from all areas of study
Results for 'Maha Hussain'
:
First person profile: Maha Hussain, MD Publication Year: 2020
DOI: https://doi.org/10.1002/cncr.32951
Abstract:
Add to Library
Authors:
The Chemotherapy Source Book Publication Year: 1992
DOI: https://doi.org/10.7326/0003-4819-117-5-448_4
Abstract:
Add to Library
Authors:
Re: Matthew R. Smith, Maha Hussain, Fred Saad, et al. Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer. N Engl J Med. 2022;386:1132–1142 Publication Year: 2022
DOI: https://doi.org/10.1016/j.eururo.2022.03.004
Abstract:
Add to Library
Authors:
Giuseppe Di Lorenzo
Carlo Buonerba
Re: Maha Hussain, Joaquin Mateo, Karim Fizazi, et al. Survival with Olaparib in Metastatic Castration-resistant Prostate Cancer. N Engl J Med. In press. https://doi.org/10.1056/NEJMoa2022485 Publication Year: 2020
DOI: https://doi.org/10.1016/j.euo.2020.10.004
Abstract:
Add to Library
Authors:
Alessandro Rizzo
Veronica Mollica
Francesco Massari
Epothilones and the next generation of phase III trials for prostate cancer Publication Year: 2005
DOI: https://doi.org/10.1111/j.1464-410x.2005.05618.x
Abstract:
Add to Library
Authors:
Manish Bhandari
Maha Hussain
Reply to Johann S. de Bono, Maha Hussain, and Jinyu Kang’s Letter to the Editor re: Konrad H. Stopsack. Efficacy of PARP Inhibition in Metastatic Castration-resistant Prostate Cancer is Very Different with Non-BRCA DNA Repair Alterations: Reconstructing Prespecified Endpoints for Cohort B from the Phase 3 PROfound Trial of Olaparib. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.09.024 Publication Year: 2020
DOI: https://doi.org/10.1016/j.eururo.2020.12.018
Abstract:
Add to Library
Authors:
Circulating Tumor Cells as Potential Biomarkers in Bladder Cancer Publication Year: 2015
DOI: https://doi.org/10.1016/j.juro.2015.02.2951
Abstract:
Add to Library
Authors:
Ajjai Alva
Terence W. Friedlander
Melanie Clark
Tamara Huebner
Stephanie Daignault
Maha Hussain
Cheryl Lee
Khaled Hafez
Brent K. Hollenbeck
Alon Z. Weizer
Gayatri Premasekharan
Tony Tran
Christine Fu
Cristian Ionescu‐Zanetti
Michael Schwartz
Andrea Fan
Pamela L. Paris
Phase II Trial of Paclitaxel, Carboplatin and Gemcitabine in Patients With Locally Advanced Carcinoma of the Bladder Publication Year: 2008
DOI: https://doi.org/10.1016/j.juro.2008.08.075
Abstract:
Add to Library
Authors:
David C. Smith
Niklas J. Mackler
Rodney L. Dunn
Maha Hussain
David P. Wood
Cheryl T. Lee
Martin G. Sanda
Ulka N. Vaishampayan
Daniel P. Petrylak
David I. Quinn
Kathleen W. Beekman
James E. Montie
Meet Maha Hussain, MD, FACP, FASCO Publication Year: 2024
DOI: https://doi.org/10.1200/acon.16.00248
Abstract:
Add to Library
Authors:
Understanding the Effects of the COVID-19 Pandemic on Infant Development—The Preterm Problem Publication Year: 2022
DOI: https://doi.org/10.1001/jamapediatrics.2021.5570
Abstract:
Add to Library
Authors:
Mollie E. Wood
Megan Delgado
Michele Jönsson Funk
Association of Body Mass Index With Response and Survival in Men With Metastatic Prostate Cancer: Southwest Oncology Group Trials 8894 and 9916 Publication Year: 2007
DOI: https://doi.org/10.1016/j.juro.2007.07.026
Abstract:
Add to Library
Authors:
Bruce Montgomery
Bryan Goldman
Catherine M. Tangen
Maha Hussain
Daniel P. Petrylak
Stephanie T. Page
Eric A. Klein
E. David Crawford
OUTCOMES FOR RADIATION THERAPY AFTER RADICAL PROSTATECTOMY FOR PROSTATE CANCER: WHAT REALLY MATTERS? Publication Year: 2007
DOI: https://doi.org/10.1111/j.1464-410x.2007.07057.x
Abstract:
Add to Library
Authors:
James E. Montie
Maha Hussain
1417 EFFICIENT DELIVERY OF RADICAL CYSTECTOMY AFTER NEOADJUVANT CHEMOTHERAPY FOR MUSCLE INVASIVE BLADDER CANCER: A MULTIDISCIPLINARY APPROACH Publication Year: 2011
DOI: https://doi.org/10.1016/j.juro.2011.02.1308
Abstract:
Add to Library
Authors:
Ajjai Alva
Christopher T. Tallman
Chang He
Maha Hussain
Khaled Hafez
James E. Montie
David C. Smith
Alon Z. Weizer
David P. Wood
Cheryl Lee
Oral etoposide in the treatment of hormone-refractory prostate cancer Publication Year: 1994
DOI: https://doi.org/10.1002/1097-0142(19940701)74:1<100::aid-cncr2820740118>3.0.co;2-k
Abstract:
Add to Library
Authors:
Maha Hussain
Kenneth J. Pienta
Bruce G. Redman
Glenn Cummings
Lawrence E. Flaherty
COMBINATION CISPLATIN, 5-FLUOROURACIL AND RADIATION THERAPY FOR LOCALLY ADVANCED UNRESECTABLE OR MEDICALLY UNFIT BLADDER CANCER CASES: A SOUTHWEST ONCOLOGY GROUP STUDY Publication Year: 2001
DOI: https://doi.org/10.1097/00005392-200101000-00014
Abstract:
Add to Library
Authors:
Maha Hussain
Tracy R. Glass
Jeffrey D. Forman
Wael Sakr
David C. Smith
Muhyi Al‐Sarraf
Jeffrey A. Jones
Stanley P. Balcerzak
E. David Crawford
H. Barton Grossman
Found 481 results in 0.114 seconds
What is Boolean Searches
Including any of the words AND, OR, or NOT in any of your searches will enable
boolean search. Those words must be UPPERCASE . You can use this in all searches, including using
the search parameter, and using search filters.
This allows you to craft complex queries using those boolean operators along with parentheses and quotation marks.
Surrounding a phrase with quotation marks will search for an exact match of that phrase, after stemming and
stop-word removal (be sure to use double quotation marks — "). Using parentheses will specify order of
operations for the boolean operators. Words that are not separated by one of the boolean operators will be
interpreted as AND.
Behind the scenes, the boolean search is using Elasticsearch's query string query on the searchable fields (such as
title, abstract, and fulltext for works; see each individual entity page for specifics about that entity). Wildcard
and fuzzy searches using *, ? or ~ are not allowed; these characters will be
removed from any searches. These searches, even when using quotation marks, will go through the same cleaning as
described above, including stemming and removal of stop words.
Example Search
Search for works that mention "elmo" and "sesame street", but not the words
"cookie" or "monster":
"elmo" AND "sesame street" NOT "cookie" NOT "monster"